Aptus Biotech - Corporate Info

Search for new therapeutic applicationsaptamers using technology, Aptus collaborates with research centers and companies that are addressing new therapeutic lines.
Diagnostic applicationsaptamers are emerging as powerful diagnostic tools. Aptus also participates in the development of new biosensors for application in clinical practice.
Aptamers selectionservicesAptus offers its Aptamer Facility and is open to collaborate on research and development of new therapeutic and diagnostic applications.
Technology withmany advantagesresemble antibodies in their diagnostic and therapeutic potential, and best performance in their high reproducibility, stability at room temperature, no immunogenicity and other properties.
With the support ofthe Ramón y Cajal Health Research InstituteAptus scientific knowhow is based on close collaboration whith the Research Institute and his team specialized in aptamers technology.

Login Form

Aptus Biotech

Aptus Biotech is a biotech start-up founded in 2010 from a collaboration agreement with the Ramon y Cajal Hospital Foundation.

Our goal is to become a leading start-up in the development of new biotechnological applications based on aptamers. Aptus management and technical team are also supported by Ramon y Cajal Foundation team, with an extensive experience in research and biomedical applications.

APTUS Biotech offers aptamer selection services: oligonucleotide Selection by SELEX method, aptamer storage through its insertion in bacteria, chemical synthesis of aptamers and binding studies with target proteins.

APTUS started from collaboration between IGEN Biotech and Instituto Ramón y Cajal Para la Investigación Sanitaria (IRyCIS), specifically with the research group led by PhD. Víctor M. González and PhD. Elena Martín. We also collaborate with other research centers aiming for developing innovative therapeutic and diagnostic tools based on aptamer technology.